{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-259530","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2026-06-05T20:05:17+00:00","discovered_at":"2026-06-05T20:07:00.238004+00:00","generated_at":"2026-06-05T20:08:48.697911+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Definitive Healthcare shareholders approve 15M share increase under 2021 equity plan","bullets":["Amendment to 2021 Equity Incentive Plan approved: shares authorized increase from 30.97M to 45.97M (15M new shares).","All three Class II director nominees elected: Chris Egan, Sastry Chilukuri, Samuel Hamood.","Deloitte & Touche LLP ratified as independent auditor for fiscal year 2026; 130.7M for, 0.7M against.","Advisory say-on-pay approved with 108.8M for, 12.7M against, 19.2k abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-259530","json":"https://secwatch.observer/filing/0001193125-26-259530.json","markdown":"https://secwatch.observer/filing/0001193125-26-259530.md","text":"https://secwatch.observer/filing/0001193125-26-259530.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000119312526259530/0001193125-26-259530-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000119312526259530/dh-20260604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T20:08:48.697911+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4d17b216456e1870c81e5ae156e83953ef748930","claim":"Definitive Healthcare Corp. shareholders approved Election of each of the nominees for Class II directors at the 2026-06-04 meeting.","evidence_excerpt":"Proposal 1 – Election of Directors The stockholders elected each of the three nominees named below as Class II directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified. The results of such vote were: Director Nominee For Withheld Broker Non-Votes Chris Egan 115,632,170 5,879,043 10,023,267 Sastry Chilukuri 114,385,076 7,126,137 10,023,267 Samuel A. Hamood 118,977,114 2,534,099 10,023,267","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000119312526259530/0001193125-26-259530-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"},{"claim_id":"906e59174a96cc690f0c47ea46b351598574919d","claim":"Definitive Healthcare Corp. shareholders approved Advisory vote on the compensation of the Company's named executive officers at the 2026-06-04 meeting.","evidence_excerpt":"Proposal 4 – Advisory Vote on Executive Compensation The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The results of such vote were: For Against Abstain Broker Non-Votes 108,811,271 12,680,719 19,223 10,023,267","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000119312526259530/0001193125-26-259530-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"},{"claim_id":"a506ff48db6757273f1f5afae0f17417f01d681a","claim":"Definitive Healthcare Corp. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-04 meeting.","evidence_excerpt":"Proposal 2 – Ratification of Selection of Independent Public Registered Accounting Firm The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. The results of such vote were: For Against Abstain 130,745,809 726,699 61,972","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000119312526259530/0001193125-26-259530-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"},{"claim_id":"d2a35ad55274b237823025887125990853bdc0d7","claim":"Definitive Healthcare Corp. shareholders approved Approval of an amendment to the Definitive Healthcare Corp. 2021 Equity Incentive Plan to increase the number of shares of Class A common stock available for grant by 15,000,000 at the 2026-06-04 meeting.","evidence_excerpt":"Proposal 3 – Share Increase Proposal The stockholders approved an amendment to the 2021 Plan, to increase the number of shares of Common Stock that we will have authority to grant under the 2021 Plan by 15,000,000 from 30,972,789 to 45,972,789. The results of such vote were: For Against Abstain Broker Non-Votes 105,140,642 16,351,580 18,991 10,023,267","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000119312526259530/0001193125-26-259530-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}